These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21254995)

  • 1. Sugammadex and rescue reversal.
    Mirakhur RK; Shields MO; de Boer HD
    Anaesthesia; 2011 Feb; 66(2):140-1; author reply 141. PubMed ID: 21254995
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex and residual neuromuscular block: what is acceptable normal practice?
    Todd MM
    Br J Anaesth; 2016 Mar; 116(3):434-5. PubMed ID: 26865140
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
    Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
    Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
    Kiss G; Lacour A; d'Hollander A
    Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
    [No Abstract]   [Full Text] [Related]  

  • 5. Is one acceleromyographically measured train-of-four ratio sufficient after sugammadex to identify residual curarization in postoperative, awake patients?
    Unterbuchner C
    Br J Anaesth; 2016 Mar; 116(3):433-4. PubMed ID: 26865139
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability and storage of sugammadex for emergency use.
    Ackerman AG; Russ S; Puttick N; Kessell G
    Anaesthesia; 2011 Feb; 66(2):139-40. PubMed ID: 21254994
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden universality of residual neuromuscular block.
    Eikermann M
    Br J Anaesth; 2016 Mar; 116(3):435-6. PubMed ID: 26865141
    [No Abstract]   [Full Text] [Related]  

  • 9. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' scenario?
    Dada A; Dunsire F
    Anaesthesia; 2011 Feb; 66(2):141-2. PubMed ID: 21254997
    [No Abstract]   [Full Text] [Related]  

  • 10. Sugammadex in a patient with Sjogren's syndrome and polymyositis.
    Carron M; Ieppariello G; Ori C
    Br J Anaesth; 2013 Dec; 111(6):1034-5. PubMed ID: 24233320
    [No Abstract]   [Full Text] [Related]  

  • 11. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Mercer SJ; Moneypenny MJ
    Anaesthesia; 2011 Mar; 66(3):223-4. PubMed ID: 21320093
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Sugammadex for Neuromuscular Reversal in Cardiac Transplant Patients.
    Varela N; Golvano M; Pérez-Pevida B
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):e37. PubMed ID: 27222050
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnesium sulphate effects on sugammadex reversal time - a reply.
    Germano Filho PA
    Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
    [No Abstract]   [Full Text] [Related]  

  • 16. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Bisschops MM; Holleman C; Huitink JM
    Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation.
    Carron M; Ori C
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK; Kristen P; Rex C
    Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex in patients with myasthenia gravis.
    De Boer HD; Van Egmond J; Driessen JJ; Booij LHJD
    Anaesthesia; 2010 Jun; 65(6):653. PubMed ID: 20565409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.